Charles River Laboratories Hits Day High with 7.58% Surge in Stock Price

Charles River Laboratories International, Inc. has experienced a significant uptick in its stock performance, gaining 7.58% on May 5, 2026. The stock reached an intraday high of USD 185.39, reflecting a strong day of trading for the small-cap company operating within the miscellaneous industry. In terms of performance metrics, Charles River Laboratories has shown notable resilience over the past week, with an 11.15% increase compared to the S&P 500's 1.69% rise. Over the past month, the stock has gained 6.61%, although it has underperformed the S&P 500 over the year with a return of 55.22% versus the index's 28.47%. Despite the recent gains, the company has faced challenges, including a decline in net profit and a lower return on capital employed. The stock's price-to-earnings ratio stands at 23.00, and it currently has a market capitalization of USD 7,503 million. Investors may want to consider these factors as they evaluate the stock's performance in the context of broader market trends.